In this roundup feature focusing on the developments in digital health, we highlight the key news and announcements from June.

The American Diabetes Association held its 81st Scientific Sessions from 25-29 June, where a range of presentations covering clinical trials of continuous glucose monitors, insulin-delivery systems and remote monitoring technologies were given.

The UK-headquartered life sciences investment firm has comfortably exceeded its target of $350m for a fund dedicated to taking on late-stage products, incurring all the clinical and regulatory risk and receiving a pre-negotiated return once the drug is approved.

The pandemic has shaken up investor priorities and changed the outlook for health care start-ups – or has it? Nooman Haque managing director, life sciences and healthcare at Silicon Valley Bank, gives his view of what has changed over the past year, and looks at future trends.